Skip to content

Study Details

Study Ozanimod an Approved Drug for People with Crohns Disease

(IRB#: IRB_00115515)

Crohns disease (CD) can cause severe pain and swelling in a persons stomach. Ozanimod is an approved drug that can help people with this disease. We are doing this research to know more about how well ozanimod works. The information we learn in this study will aid future patients.

I AM INTERESTED

  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18-75
  • Diagnosis of CD with symptoms at least 3 months before participation
  • Women who can become pregnant must use a birth control method
  • In-person at the University of Utah

Exclusion Criteria

  • History of diabetes
  • History of cancer
  • History of alcohol or drug abuse 1 year before participation
  • Participation in another ozanimod study
  • Pregnant

Will I be paid for my time?

Yes

For more information contact:

Julie Will

julie.will@hsc.utah.edu

  801-581-7802

IRB#: IRB_00115515

PI: Jessica Johnson

Department: GASTROENTEROLOGY

Approval Date: 2019-07-31 06:00:00

Specialties: Gastroenterology

Last Updated: 6/8/23